Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT1 | Q99873 | 3/20 | 0.61 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.61 |
| ▸ | CD40 | P25942 | 1/20 | 0.48 |
| ▸ | CD40LG | P29965 | 1/20 | 0.48 |
| ▸ | ENPP2 | Q13822 | 10/20 | 0.47 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.47 |
| ▸ | EP300 | Q09472 | 1/20 | 0.47 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.47 |
| ▸ | FUT8 | Q9BYC5 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.42 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3698096 | 1.00 | PRMT1 (0.61) | PRMT1CARM1CD40CD40LGENPP2 | |
| SCHEMBL14388947 | 0.94 | PRMT1 (0.53) | PRMT1CARM1CD40CD40LGENPP2 | |
| SCHEMBL14388852 | 0.92 | PRMT1 (0.53) | PRMT1CARM1CD40CD40LGENPP2 | |
| SCHEMBL14388920 | 0.90 | FUT8 (0.54) | PRMT1CARM1CD40CD40LGENPP2 | |
| SCHEMBL15545001 | 0.89 | PRMT1 (0.71) | PRMT1CARM1CD40CD40LGENPP2 | |
| SCHEMBL15545004 | 0.89 | PRMT1 (0.71) | PRMT1CARM1CD40CD40LGENPP2 | |
| SCHEMBL14388936 | 0.88 | PRMT1 (0.56) | PRMT1CARM1CD40CD40LGENPP2 | |
| SCHEMBL11671160 | 0.88 | PRMT1 (0.68) | PRMT1CARM1CD40CD40LGENPP2 | |
| SCHEMBL29770470 | 0.86 | PRMT1 (0.61) | PRMT1CARM1CD40CD40LGENPP2 | |
| SCHEMBL13880626 | 0.85 | FUT8 (0.50) | PRMT1CARM1CD40CD40LGENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2877538-B1 | HOME FABRIC DYE PRODUCT | HENKEL AG & CO KGAA (DE) | 2017-09-06 | — | — | EP | claimed |
| US-9403987-B2 | Charged particles | BASF SE (DE) | 2016-08-02 | — | — | US | disclosed |
| US-9403987-B2 | Charged particles | BASF SE (DE) | 2016-08-02 | — | — | US | disclosed |
| US-8367823-B2 | Colorants based N-halamines compositions and method of making and using | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2013-02-05 | — | — | US | disclosed |
| US-20120229884-A1 | CHARGED PARTICLES | BASF SE (DE) | 2012-09-13 | — | — | US | disclosed |
| US-20120229884-A1 | CHARGED PARTICLES | BASF SE (DE) | 2012-09-13 | — | — | US | disclosed |
| WO-2010149505-A2 | CHARGED PARTICLES | BASF SE (DE) | 2010-12-29 | — | — | WO | disclosed |
| US-20090074825-A1 | COLORANTS BASED N-HALAMINES COMPOSITIONS AND METHOD OF MAKING AND USING | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2009-03-19 | — | — | US | disclosed |
| US-20070271711-A1 | Dye Mixtures of Fibre-Reactive Azo Dyes Production and Use Thereof | DYSTAR TEXTILFARBEN GMBH & CO., DEUTSCHLAND KG (DE) | 2007-11-29 | — | — | US | disclosed |
| WO-2007039573-A2 | AZO REACTIVE DYES AND MIXTURES OF FIBER-REACTIVE AZO DYES, THEIR PREPARATION AND THEIR USE | DYSTAR TEXTILFARBEN GMBH & CO DEUTSCHLAND KG (DE) | 2007-04-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090074825-A1 | COLORANTS BASED N-HALAMINES COMPOSITIONS AND METHOD OF MAKING AND USING | TYR, MPO, NISCH | PRMT1 949/4885CARM1 988/4885CD40 4885/4885 |
| US-20120229884-A1 | CHARGED PARTICLES | POLE3, POLD3, IPO4 | PRMT1 4254/4885CARM1 4276/4885CD40 4303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.